Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study

PURPOSE: Pasireotide is an effective treatment for acromegaly and Cushing’s disease, although treatment-emergent hyperglycemia can occur. The objective of this study was to assess incretin-based therapy versus insulin for managing pasireotide-associated hyperglycemia uncontrolled by metformin/other...

Descripción completa

Detalles Bibliográficos
Autores principales: Samson, Susan L., Gu, Feng, Feldt-Rasmussen, Ulla, Zhang, Shaoling, Yu, Yerong, Witek, Przemysław, Kalra, Pramila, Pedroncelli, Alberto M., Pultar, Philippe, Jabbour, Nadine, Paul, Michaela, Bolanowski, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550309/
https://www.ncbi.nlm.nih.gov/pubmed/34275099
http://dx.doi.org/10.1007/s11102-021-01161-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550309/
https://www.ncbi.nlm.nih.gov/pubmed/34275099
http://dx.doi.org/10.1007/s11102-021-01161-4

Ejemplares similares